Voloridge Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Voloridge Investment Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,119	Closed	-$696K	–	1665
2023 Q2	$696K	Buy	+18,119	New	+$465K	﹤0.01%	1182
2022 Q4	–	Sell	-58,881	Closed	-$1.16M	–	1689
2022 Q3	$1.16M	Buy	58,881 +7,941	+16%	+$159K	0.01%	1123
2022 Q2	$891K	Buy	+50,940	New	+$800K	﹤0.01%	1216

Voloridge Investment Management's KDNY Position: Q3 2023 in Review

Voloridge Investment Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 18,119 shares — an estimated $696K sold.

Voloridge Investment Management first reported a position in KDNY in Q2 2022 and held it in 3 quarters. The position peaked at $1.16M in Q3 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Voloridge Investment Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Voloridge Investment Management sold 18,119 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $696K.
Voloridge Investment Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Voloridge Investment Management's Chinook Therapeutics, Inc. Common Stock position peaked at $1.16M in Q3 2022.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.